RedHill Biopharma Ltd. (RDHL) NASDAQ
0.83
-0.045(-5.14%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
0.83
-0.045(-5.14%)
Currency In USD
| Market Cap | 15.3M |
| Enterprise Value | 11.04M |
| P/E Ratio | -0.16 |
| PEG Ratio | -0 |
| Price/Sales Ratio | 0.29 |
| Price/Book Ratio | -0.34 |
| Enterprise/Revenue | 0.01 |
| Enterprise/EBITDA | -0.01 |
| Fiscal Year | December 31, 2024 |
| Most Recent Quarter | June 30, 2025 |
| Profit Margin | -0.98 |
| Operating Margin | -1.1 |
| Return On Assets | -0.51 |
| Return On Equity | 2.05 |
| Revenue | 8.04M |
| Revenue/Share | 5.3 |
| Gross Profit | 4.85M |
| EBITDA | -7.59M |
| Net Income | -8.27M |
| Diluted EPS | -7 |
| Total Cash | 2.87M |
| Total Cash/Share | 1.59 |
| Total Debt | 214,000 |
| Total Debt/Equity | -0.05 |
| Current Ratio | 0.56 |
| Book Value Per Share | -2.45 |
| 52-Week Change | -70.98 |
| 52-Week High | 3.31 |
| 52-Week Low | 0.8 |
| Moving Average 50 Days | 1.1 |
| Moving Average 200 Days | 1.43 |
| Average Volume | 497,410 |
| Shares Outstanding | 3.33M |
| % Held by Institutions | 0.01 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:25 |
| Last Split Date | August 20, 2024 |